Surgery – Blood vessel or graft preparation
Reexamination Certificate
2008-09-30
2008-09-30
Gilbert, Samuel G (Department: 3735)
Surgery
Blood vessel or graft preparation
Reexamination Certificate
active
11238717
ABSTRACT:
A dural graft is provided having improved stiffness characteristics relative to conventional dural substitutes. The dural graft can be formed from a collagen material having a stiffness between about 0.1 pounds per inch (lb./in.) and 0.25 lb./in. Relative to the collagen material forming conventional dural graft substitutes, the decreased stiffness of the collagen material of the present dural graft can provide the graft with a relatively improved or increased pliability. As a result of the increased pliability, the dural graft can sufficiently conform to a curvature of a tissue surface to which it is applied, such as the curved surface of a meningeal membrane. The reduced stiffness of the collagen material can also provide for a relatively improved or increased flexibility or elasticity of the dural graft. The increased flexibility of the dural graft minimizes tearing of the graft when handled or manipulated during an implantation procedure.
REFERENCES:
patent: 2465357 (1949-03-01), Correll
patent: 2492458 (1949-12-01), Bering
patent: 3157524 (1964-11-01), Artandi
patent: 3364200 (1968-01-01), Aston et al.
patent: 3520402 (1970-07-01), Nichols
patent: 3632361 (1972-01-01), Battista
patent: 3742955 (1973-07-01), Battista
patent: 3800792 (1974-04-01), McKnight et al.
patent: 3939831 (1976-02-01), Cioca et al.
patent: 4006220 (1977-02-01), Gottieb
patent: 4016877 (1977-04-01), Cruz, Jr.
patent: 4066083 (1978-01-01), Ries
patent: 4089333 (1978-05-01), Utsuo et al.
patent: 4140537 (1979-02-01), Luck et al.
patent: 4148664 (1979-04-01), Cruz, Jr.
patent: 4185011 (1980-01-01), Eckmayer et al.
patent: 4215200 (1980-07-01), Miyata et al.
patent: 4233360 (1980-11-01), Luck et al.
patent: 4238480 (1980-12-01), Sawyer
patent: 4271070 (1981-06-01), Miyata et al.
patent: 4294241 (1981-10-01), Miyata
patent: 4404033 (1983-09-01), Steffan
patent: 4404970 (1983-09-01), Sawyer
patent: 4407787 (1983-10-01), Stemberger
patent: 4412947 (1983-11-01), Cioca
patent: 4522753 (1985-06-01), Yannas et al.
patent: 4578067 (1986-03-01), Cruz, Jr.
patent: 4600533 (1986-07-01), Chu
patent: 4606910 (1986-08-01), Sawyer
patent: 4655980 (1987-04-01), Chu
patent: 4689399 (1987-08-01), Chu
patent: 4725671 (1988-02-01), Chu et al.
patent: 4738849 (1988-04-01), Sawyer
patent: 4798800 (1989-01-01), Timpl et al.
patent: 4837285 (1989-06-01), Berg et al.
patent: 4947840 (1990-08-01), Yannas et al.
patent: 4948540 (1990-08-01), Nigam
patent: 4970298 (1990-11-01), Silver et al.
patent: 5019087 (1991-05-01), Nichols
patent: 5028695 (1991-07-01), Eckmayer et al.
patent: 5071878 (1991-12-01), Herschler
patent: 5110604 (1992-05-01), Chu et al.
patent: 5171574 (1992-12-01), Kuberasampath et al.
patent: 5201745 (1993-04-01), Tayot et al.
patent: 5209776 (1993-05-01), Bass et al.
patent: 5215904 (1993-06-01), Gould et al.
patent: 5227301 (1993-07-01), Turner et al.
patent: 5412076 (1995-05-01), Gagnieu
patent: 5512301 (1996-04-01), Song et al.
patent: 5567806 (1996-10-01), Abdul-Malak et al.
patent: 5580923 (1996-12-01), Yeung et al.
patent: 5667839 (1997-09-01), Berg
patent: 5677839 (1997-10-01), Kondo
patent: 5895412 (1999-04-01), Tucker
patent: 5931800 (1999-08-01), Rasmussen et al.
patent: 5997895 (1999-12-01), Narotam et al.
patent: 6149609 (2000-11-01), Lieberman et al.
patent: 6270793 (2001-08-01), Van Dyke et al.
patent: 6274155 (2001-08-01), Van Dyke et al.
patent: 6361551 (2002-03-01), Torgerson et al.
patent: 6454787 (2002-09-01), Maddalo et al.
patent: 6461628 (2002-10-01), Blanchard et al.
patent: 2003/0220334 (2003-11-01), Wender et al.
patent: 2004/0028738 (2004-02-01), Huang et al.
patent: 0667352 (1995-01-01), None
patent: 0 440 198 (1995-11-01), None
patent: 0742018 (1996-11-01), None
patent: 0 877 761 (2001-05-01), None
patent: 05250694.6 (2006-01-01), None
patent: 08041425 (1996-02-01), None
patent: WO 9420133 (1994-09-01), None
patent: WO 9625961 (1996-02-01), None
patent: WO 9617633 (1996-06-01), None
patent: WO 9640174 (1996-06-01), None
patent: WO 9728192 (1997-01-01), None
patent: WO9737694 (1997-04-01), None
patent: WO 9728193 (1997-08-01), None
patent: WO 99/13902 (1999-03-01), None
Thompson et al., “Hemorrhage Associated with Silastic Dural Substitute”,J. of Neurology, Neurosurgery&Psychiatry, 1994, 57: 646-648.
Taylor et al., “Unconventional Transmissible Agents in Dura Matter: Significance for latrogenic Creutzfeldt-Jakob Disease”,Neuropathology&Applied Neurobiology, 1996, 22: 259-260.
D.G. Kline, “Dural Replacement with Resorbable Collagen”,Arch Surg, 1965 91: 924-929.
Doillon et al., “Transmission of Creutzfeldt-Jakob Disease by Handling of Dura Matter”,The Lancet, 1993, 341: 123-124.
Janetta et al., “Formaldehyde-Treated Regenerated Collagen Film and Film-Laminate as a Substitute for Dura Mater”, Proceedings of the 21stAnnual Sessions of the Forum on Fundamental Surgical Problems, 51stClinical Congress of the American College of Surgeons, Atlantic City, New Jersey, 1965, Surgical Forum, vol. XVI, pp. 435-437.
Collins et al., “Use of Collagen Film as Dural Substitute: Preliminary Animal Studies”,J. of Biomedical Material Research, 1991, 25:267-276.
Doillon et al., “Chemical Inactivators as Sterilization Agents for Bovine Collagen Materials”, National library of Medicine Medline Database, TBIS, 2003, Abstract, p. 3.
Dormont, D., “How to Limit the Spread of Creutzfeldt-Jakob Disease”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 4.
Rohwer, R.G., “Analysis of Risk to Biomedical Products Developed from Animal Sources (with Special Emphases on the Spongiform Encephalopathy Agents, Scrapie and BSE)”, National Library of Medicine Medline Database, TBIS, 2003, abstract, p. 5.
Safar, J. et al., “Thermal Stability and Conformational Transitions of Scrapie Amyloid (Prion) Protein Correlate with Infectivity”, National Library of Medicine Medline Databse, TBIS, 2003, Abstract, p. 5.
Taylor, D.M., “Inactiviation of SE Agents”, National Library of Medicine Medline Database TBIS, 2003, Abstract, p. 6.
Ernst & Race, “Comparative Analysis of Scrapie Agent Inactivation Methods”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 6.
DiMartino et al., “Inactivation of the Scrapie Agent in a Scaled-down Procedure for the Purification of Gangliosides from Brain Tissue”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 7.
Tateishi et al., “Practical Methods for chemical Inactivation of Creutzfeldt-Jakob Disease Pathogen”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 7.
Taylor, D. M., “Inactivation of BSE Agent”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 7.
Brown et al., “A Simple and Effective Method for Inactivating Virus Infectivity in Formalin-fixed Tissue Samples from Patients with Creutzfeldt-Jakob Disease”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 8.
Dees et al., “Inactivation of the Scrapie Agent by Ultraviolet Irradiation in the Presence of Chlorpromazine”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 9.
Cho, H. J., “Inactivation of the Scrapie Agent by Pronase”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 10.
Brown et al., “Effect of Chemicals, Heat and Histopathologic Processing on High-Infectivity Hamster-Adapted Scrapie Viirus”, National Library of Medicine Medline Database, TBIS, 2003, Abstract, p. 10.
Cox., “A Systematic Review of the Published Literature to Identify the Methods of Inactivation for Unconventional Agents of Transmissible Spongiform Encephalopathies”, Medical Devices Agency, UK, 2001, pp. 1-13.
Archibald et al., “Long Term Maintenance of Axonal Regeneration in Primates Following Collagen Nerve Guide Repair of 2CMMedian Nerve Deficit”,Society for Neuroscience Abstracts, 1992,
Codman & Shurtleff Inc.
Gilbert Samuel G
Nutter & McClennen & Fish LLP
LandOfFree
Dural graft and method of preparing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dural graft and method of preparing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dural graft and method of preparing the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3951332